Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-07-10-Speech-2-342"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20070710.55.2-342"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
".
Mrs Stihler, I should like to start by assuring you that we fully agree on the political assessment that the door must not be opened to product advertising in the field of prescription medicinal products; nor will this happen if I can help it. The sole objective must be to provide patients with objective, comprehensive, neutral information, and to do so in such a way as to avoid confusing them, and as to ensure that they all have equal access to this objective, neutral information.
The problem we face today is that some groups of patients have access to all manner of information via the Internet and other modern communication technologies, whereas many patients do not have this information, and that is a situation we must eliminate.
I should like to reiterate quite clearly that we shall not cross the line separating patient information from product advertising. In addition, we shall lay down quite clearly what rules and criteria apply to the information concerned.
Regarding the timetable, I said before that the consultation stage has been concluded. We are now working at full stretch towards completing the final report on the basis of these consultations. As I said before, I shall do my utmost to speed this process up. At all events, it will be complete by the end of this year."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples